78 related articles for article (PubMed ID: 8393381)
41. Long-lasting decrease of marrow and circulating long-term culture initiating cells after allogeneic bone marrow transplant.
Selleri C; Maciejewski JP; De Rosa G; Raiola A; Risitano AM; Picardi M; Pezzullo L; Luciano L; Ricci P; Varriale G; Della Cioppa P; Del Vecchio L; Rotoli B
Bone Marrow Transplant; 1999 May; 23(10):1029-37. PubMed ID: 10373069
[TBL] [Abstract][Full Text] [Related]
42. Hematopoietic recovery of ex vivo perfusion culture expanded bone marrow and unexpanded peripheral blood progenitors after myeloablative chemotherapy.
Engelhardt M; Douville J; Behringer D; Jähne A; Smith A; Henschler R; Lange W
Bone Marrow Transplant; 2001 Feb; 27(3):249-59. PubMed ID: 11277172
[TBL] [Abstract][Full Text] [Related]
43. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia.
Betticher DC; Huxol H; Müller R; Speck B; Nissen C
Exp Hematol; 1993 Nov; 21(12):1517-21. PubMed ID: 8405233
[TBL] [Abstract][Full Text] [Related]
44. Hepatocyte growth factor/scatter factor (HGF/SF) is produced by human bone marrow stromal cells and promotes proliferation, adhesion and survival of human hematopoietic progenitor cells (CD34+).
Weimar IS; Miranda N; Muller EJ; Hekman A; Kerst JM; de Gast GC; Gerritsen WR
Exp Hematol; 1998 Aug; 26(9):885-94. PubMed ID: 9694510
[TBL] [Abstract][Full Text] [Related]
45. Bone marrow-resident memory T cells survive pretransplant chemotherapy and contribute to early immune reconstitution of patients with acute myeloid leukemia given mafosfamide-purged autologous bone marrow transplantation.
Casorati G; Locatelli F; Pagani S; Garavaglia C; Montini E; Lisini D; Turin I; Rossi F; Dellabona P; Maccario R; Montagna D
Exp Hematol; 2005 Feb; 33(2):212-8. PubMed ID: 15676215
[TBL] [Abstract][Full Text] [Related]
46. Single leukapheresis products collected from healthy donors after the administration of granulocyte colony-stimulating factor contain ten-fold higher numbers of long-term reconstituting hematopoietic progenitor cells than conventional bone marrow allografts.
Theilgaard-Mönch K; Raaschou-Jensen K; Andersen H; Russell CA; Vindeløv L; Jacobsen N; Dickmeiss E
Bone Marrow Transplant; 1999 Feb; 23(3):243-9. PubMed ID: 10084255
[TBL] [Abstract][Full Text] [Related]
47. Quantitation of GD2 synthase mRNA by real-time reverse transcription-polymerase chain reaction: utility in bone marrow purging of neuroblastoma by anti-GD2 antibody 3F8.
Cheung IY; Lo Piccolo MS; Collins N; Kushner BH; Cheung NK
Cancer; 2002 Jun; 94(11):3042-8. PubMed ID: 12115395
[TBL] [Abstract][Full Text] [Related]
48. Clinical outcomes and graft characteristics in pediatric matched sibling donor transplants using granulocyte colony-stimulating factor-primed bone marrow and steady-state bone marrow.
Chiang KY; Haight A; Horan J; Olson E; Gartner A; Hartman D; Youssef S; Worthington-White D
Pediatr Transplant; 2007 May; 11(3):279-85. PubMed ID: 17430483
[TBL] [Abstract][Full Text] [Related]
49. [The use of monoclonal antibodies that recognize the neural cell adhesion molecule (NCAM) in the diagnosis of bone marrow localization of small cell lung cancer].
Pasini F; Pelosi G; Santo A; Zaninelli M; Mostacci R; Masotti A; Spagnolli P; Recaldin E; Cetto GL
Minerva Med; 1994 Sep; 85(9):433-8. PubMed ID: 7936364
[TBL] [Abstract][Full Text] [Related]
50. Peripheral blood progenitor cell mobilisation alters myeloid, but not erythroid, progenitor cell self-renewal kinetics.
Marley SB; Lewis JL; Zheng B; Davidson RJ; Davis JG; McDonald C; Alenzi FQ; Goldman JM; Gordon MY
Bone Marrow Transplant; 2001 Feb; 27(3):241-8. PubMed ID: 11277171
[TBL] [Abstract][Full Text] [Related]
51. High dose therapy and autologous bone marrow versus blood cell rescue. South Island Bone Marrow Transplant Unit.
Hill GR; Inder A; Patton WN; Hart DN
N Z Med J; 1996 Feb; 109(1016):45-8. PubMed ID: 8598936
[TBL] [Abstract][Full Text] [Related]
52. Detection of occult tumor cells in peripheral blood from patients with small cell lung cancer by reverse transcriptase-polymerase chain reaction.
Bessho A; Tabata M; Kiura K; Takata I; Nagata T; Fujimoto N; Kunisada K; Ueoka H; Harada M
Anticancer Res; 2000; 20(2B):1149-54. PubMed ID: 10810412
[TBL] [Abstract][Full Text] [Related]
53. Bone marrow stromal cell defects and 1 alpha,25-dihydroxyvitamin D3 deficiency underlying human myeloid leukemias.
Blazsek I; Farabos C; Quittet P; Labat ML; Bringuier AF; Triana BK; Machover D; Reynes M; Misset JL
Cancer Detect Prev; 1996; 20(1):31-42. PubMed ID: 8907201
[TBL] [Abstract][Full Text] [Related]
54. Prediction of the ability to purge clonogenic B cell lymphoma from normal BM in vitro by heat: their survival curves correspond to a curve reflecting mortality in humans.
Moriyama Y; Goto T; Hashimoto S; Nikkuni K; Saito H; Kishi K; Takahashi M; Shibata A; Endo K
Bone Marrow Transplant; 1993 Jun; 11(6):437-41. PubMed ID: 8334423
[TBL] [Abstract][Full Text] [Related]
55. Diagnostic and therapeutic applications of monoclonal antibodies to small cell carcinoma of the lung.
Okabe T; Takaku F
Jpn J Clin Oncol; 1986 Sep; 16(3):243-52. PubMed ID: 3022033
[TBL] [Abstract][Full Text] [Related]
56. Use of SM-1 monoclonal antibody and human complement in selective killing of small cell carcinoma of the lung.
Mabry M; Speak JA; Griffin JD; Stahel RA; Bernal SD
J Clin Invest; 1985 May; 75(5):1690-5. PubMed ID: 2987309
[TBL] [Abstract][Full Text] [Related]
57. A quantitative flow cytometric method for the determination of immunotoxin-induced cell kill in marrow grafts.
van Oosterhout YV; Preijers FW; Meijerink JP; Pennings AH; de Witte T
Prog Clin Biol Res; 1994; 389():89-95. PubMed ID: 7700943
[No Abstract] [Full Text] [Related]
58. Detection of small-cell-lung-cancer cells in bone-marrow aspirates by monoclonal antibodies NCC-LU-243, NCC-LU-246 and MLuC1.
Pasini F; Pelosi G; Ledermann JA; Cetto GL
Int J Cancer Suppl; 1994; 8():53-6. PubMed ID: 8194897
[TBL] [Abstract][Full Text] [Related]
59. Clinical applications of immunocytochemistry in the monitoring of the bone marrow in small cell lung cancer (SCLC).
Hay FG; Ford A; Leonard RC
Int J Cancer Suppl; 1988; 2():8-10. PubMed ID: 2832333
[TBL] [Abstract][Full Text] [Related]
60. Design of two immunotoxins based rovalpituzumab antibody against DLL3 receptor; a promising potential opportunity.
Ataee MH; Mirhosseini SA; Mirnejad R; Rezaie E; Hosseini HM; Amani J
Res Pharm Sci; 2022 Aug; 17(4):428-444. PubMed ID: 36034078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
